Transactions
Mar. 14, 2000
IPO Opens Funding Artery for Biotech Company
McDermott Will IPO OPENS FUNDING ARTERY FOR BIOTECH COMPANY South San Francisco's ViroLogic Inc. filed for an initial public offering of $75 million of common stock. The company has yet to determine the number of shares.
McDermott Will
IPO OPENS FUNDING ARTERY
FOR BIOTECH COMPANY
South San Francisco's ViroLogic Inc. filed for an initial public offering of $75 million of common stock. The company has yet to determine the number of shares.
ViroLogic, a biotechnology company, develops and m...
IPO OPENS FUNDING ARTERY
FOR BIOTECH COMPANY
South San Francisco's ViroLogic Inc. filed for an initial public offering of $75 million of common stock. The company has yet to determine the number of shares.
ViroLogic, a biotechnology company, develops and m...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In